These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19242023)

  • 21. Stable coronary artery disease. The National Society Journals present selected research that has driven recent advances in clinical cardiology.
    Henderson RA; Timmis AD
    Arch Cardiol Mex; 2011; 81(4):351-60. PubMed ID: 22188893
    [No Abstract]   [Full Text] [Related]  

  • 22. More in-depth examination of important topics in cardiovascular medicine.
    Shaw RE
    J Invasive Cardiol; 2008 Oct; 20(10):A5. PubMed ID: 18924287
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug-eluting stent for long coronary artery disease.
    Park SJ; Kim YH
    Indian Heart J; 2008; 60(6):519-23. PubMed ID: 19276489
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
    Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meditations on secondary revascularisation in the aftermath of the SYNTAX trial.
    Garg S; Serruys PW
    EuroIntervention; 2009 May; 5 Suppl D():D14-20. PubMed ID: 19736064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiologists get wake-up call on stents.
    Mitka M
    JAMA; 2007 May; 297(18):1967-8. PubMed ID: 17488954
    [No Abstract]   [Full Text] [Related]  

  • 29. The problem of stent thrombosis associated with drug-eluting stents and the optimal duration of dual antiplatelet therapy.
    Ayyanathan S; Hersh D; Coplan NL; Garratt K
    Prev Cardiol; 2009; 12(2):59-64. PubMed ID: 19476578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-eluting stents for saphenous vein graft lesions: the limits of evidence.
    Bittl JA
    J Am Coll Cardiol; 2009 Mar; 53(11):929-30. PubMed ID: 19281921
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug-eluting stents in patients with ESRD on dialysis: a small step forward.
    Ziada KM; Abdel-Latif A
    Am J Kidney Dis; 2009 Aug; 54(2):197-200. PubMed ID: 19619843
    [No Abstract]   [Full Text] [Related]  

  • 32. Uncertainty dogs Zetia and Vytorin.
    Harv Heart Lett; 2008 Nov; 19(3):7. PubMed ID: 19031588
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cardiology -- what is new?].
    Hoppe UC; Erdmann E
    Dtsch Med Wochenschr; 2005 Jun; 130(25-26):1540-2. PubMed ID: 15965857
    [No Abstract]   [Full Text] [Related]  

  • 34. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry).
    Fröbert O; Lagerqvist B; Carlsson J; Lindbäck J; Stenestrand U; James SK
    J Am Coll Cardiol; 2009 May; 53(18):1660-7. PubMed ID: 19406341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-eluting stents: a comprehensive appraisal.
    Butt M; Connolly D; Lip GY
    Future Cardiol; 2009 Mar; 5(2):141-57. PubMed ID: 19371189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing seasons; measuring clinical options and practice.
    Serruys PW
    EuroIntervention; 2011 Mar; 6(8):907. PubMed ID: 21330234
    [No Abstract]   [Full Text] [Related]  

  • 37. News from the 2008 ESC Congress: combination therapy with perindopril and amlodipine.
    Cardiovasc J Afr; 2008; 19(5):271-2. PubMed ID: 18997990
    [No Abstract]   [Full Text] [Related]  

  • 38. The use of drug-eluting stents in venous coronary artery bypass grafts.
    Hernandez-Antolín R; Alfonso F; Jimenez P
    EuroIntervention; 2009 May; 5 Suppl D():D51-7. PubMed ID: 19736072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late stent thrombosis after drug-eluting stent: seeing is understanding.
    Wijns W
    Circulation; 2009 Aug; 120(5):364-5. PubMed ID: 19620496
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of outcomes using bare metal versus drug-eluting stents in coronary artery disease patients with and without human immunodeficiency virus infection.
    Ren X; Trilesskaya M; Kwan DM; Nguyen K; Shaw RE; Hui PY
    Am J Cardiol; 2009 Jul; 104(2):216-22. PubMed ID: 19576350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.